| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Trimethoprim measurement (procedure) |
Component |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Trimethoprim poisoning |
Causative agent (attribute) |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Accidental trimethoprim poisoning |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Intentional trimethoprim poisoning |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| intoxication par la triméthoprime d'intention indéterminée |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Trimethoprim adverse reaction |
Causative agent (attribute) |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Allergy to trimethoprim (finding) |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Trimethoprim overdose |
Causative agent (attribute) |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Accidental trimethoprim overdose |
Causative agent (attribute) |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Intentional trimethoprim overdose |
Causative agent (attribute) |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| surdose de triméthoprime d'intention indéterminée |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Trimethoprim 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Trimethoprim 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Trimethoprim 50mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Trimethoprim 20mg/mL injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Product containing trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Trimethoprim 10 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Polymyxin b sulfate + trimethoprim sulfate 10000unt/1mg ophthalmic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole + trimethoprim 200mg/40mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole + trimethoprim 400mg/80mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole + trimethoprim 800mg/160mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole 400mg/trimethoprim 80mg infusion solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole 80mg/trimethoprim 16mg infusion solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Polymyxin B sulfate+trimethoprim eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Polymyxin B sulfate+trimethoprim eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Product containing sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Polymyxin b sulfate + trimethoprim sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Trimethoprim hydrochloride (substance) |
Is a |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Product containing phenazopyridine hydrochloride and sulfamethoxazole and trimethoprim |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Accidental trimethoprim poisoning |
Causative agent (attribute) |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Intentional trimethoprim poisoning |
Causative agent (attribute) |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| intoxication par le sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| intoxication accidentelle par le sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| intoxication intentionnelle par le sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| intoxication par le sulfaméthoxazole et triméthoprime d'intention indéterminée |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Sulfamethoxazole + trimethoprim adverse reaction |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| allergie aux sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| surdose de sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| surdose accidentelle de sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| surdose intentionnelle de sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| surdose de sulfaméthoxazole et triméthoprime d'intention indéterminée |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Co-trimoxazole 80mg/400mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Co-trimoxazole 160mg/800mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Co-trimoxazole 40mg/80mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Trimethoprim 40mg/Sulfamethoxazole200mg 5mL pediatric suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| cotrimoxazole 16 mg/80 mg/mL, ampoule de 5 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Co-trimoxazole 40mg/200mg/5mL pediatric s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Co-trimoxazole 960mg/10mL intravenous infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Product containing sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Sulfamethoxazole- and trimethoprim-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Sulfonamide/trimethoprim reaction |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Sulfonamides and trimethoprim |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Co-trimoxazole [generic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Co-trimoxazole [proprietary] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Co-trimoxazole 16mg/80mg/mL infusion solution 20mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Product containing polymyxin B and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Product containing trimethoprim in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Product containing trimethoprim in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Product containing trimethoprim in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Allergy to trimethoprim (finding) |
Causative agent (attribute) |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| allergie aux sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| allergie aux sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| allergie aux sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
3 |
| sulfaméthoxazole et triméthoprime |
Is a |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Trimethoprim 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Trimethoprim 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Trimethoprim 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Trimethoprim 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Trimethoprim 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Trimethoprim 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Trimethoprim 10 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Trimethoprim 10 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| sulfaméthoxazole et triméthoprime |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
| Product containing precisely sulfamethoxazole 800 milligram/10 milliliter and trimethoprim 160 milligram/10 milliliter conventional release solution for infusion ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sulfamethoxazole 800 milligram/10 milliliter and trimethoprim 160 milligram/10 milliliter conventional release solution for infusion ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 40 mg/mL and trimethoprim 8 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Sulfamethoxazole 40 mg/mL and trimethoprim 8 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely trimethoprim 100 milligram/5 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely trimethoprim 100 milligram/5 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
| Trimethoprim hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]